Filters

Australia-India: Leveraging digital technologies for health outcomes

Policy & Practice Report

Health Star Rating system

Policy & Practice Report

Roads to health for Aboriginal and Torres Strait Islander people

Policy & Practice Report

The future of women's health: Using data and research to shape policy

Policy & Practice Report

Mental health of Scheduled Tribe populations in India

Policy & Practice Report

Epidemiology, risk factors and outcomes of Acute Kidney Injury (PERFORM-AKI) Study

Background Acute kidney injury (AKI) is a condition where the kidneys are damaged, and their function reduced. This can lead to a build-up of fluid in the body, decreased urine output and an increase in toxins in the blood. AKI may be short-term, with people recovering the function of their kidneys. In other people, the disease progresses, and mortality rates can be as high as 45%. In adults who are admitted to hospital, up to 20% will be diagnosed with AKI as the primary reason for being admitted. Research from both Australia and the US have shown the rate of AKI to have increased greatly over the past 10 years, and that this trend will continue to rise. With significant impacts on people’s quality of life, AKI is an increasing global healthcare issue. Most research into the incidence of AKI is from within the intensive care unit (ICU). However, the rate of AKI diagnosed outside the ICU is much larger. This can be due to physical injury to the kidneys, kidney stones, infection of the kidneys, dama

Stopping Sepsis: A National Action Plan

Policy & Practice Report

Women’s health through life course and empowerment

Policy & Practice Report

Accelerating Research and Development in NSW

Policy & Practice Report

Clinical and community trial

About the study Chronic Obstructive Pulmonary Disease (COPD) is the third-leading cause of global health-related disease and deaths. Heart disease is very common in people diagnosed with COPD and is often the cause of health-related sickness and hospitalisations, causing 30 – 50% of deaths. Studies repeatedly show that heart disease is often not diagnosed in persons with COPD, and when it is diagnosed it is often under-treated. People with COPD are also commonly not included in clinical trials of drugs which treat heart disease and heart-related deaths. Beta (β)-blockers are medications often used to treat heart disease. In this study, we will be investigating whether pro-active treatment with a β-blocker in people with COPD can reduce heart-related events, such as strokes and heart attacks. This is important for people with COPD with either known or unknown underlying heart disease. The study also aims to investigate whether this treatment influences number of respiratory flare ups (exace

Clinical and community trial

About this study Australians are increasingly shopping online for their groceries however we don’t have much evidence on the level of influence of information available to consumers online. The aim of this research is to understand how online grocery purchasing choices may change depending on the information being presented online. Recruitment criteria Aged 18-75 Have high blood pressure Diagnosed by your doctor or currently taking a stable dose of blood pressure lowering medications Regularly purchase most of their groceries online from Woolworths and plan to continue for the duration of the study (4 months) or for those who don’t currently shop with Woolworths, you will also be eligible if you switch to shopping at Woolworths for the duration of the study Would be willing to shop for their groceries online for the study What’s involved? Participants will be asked to complete the following research activities if they consent to join t

Participation in the Third WHO Infodemic Manager Training

Background An infodemic according to the WHO is “an overabundance of information, both online and offline”, and typically accompanies outbreaks and pandemics e.g. COVID-19. Mis- and dis-information have wide ranging serious and adverse impacts on individuals, communities and health systems, and undermines public health responses to COVID-19. The 3rd WHO IM training is aimed to address the critical and urgent global need to develop capacity in infodemic management interventions and practice to understand and mitigate the impact of infodemics in a timely manner. Aim The 3rd IM training is aimed to build capacity so that trainees will be able to apply their knowledge and skills gained in national preparedness and response to infodemics and support the development of networks for knowledge and resource exchange The training will encompass global and region-specific topics in the infodemic and health misinformation Research Methodology The virtual tr